US 11884715
Activin receptor type IIB variants and methods of use thereof
granted A61KA61K38/00A61K38/1709
Quick answer
US patent 11884715 (Activin receptor type IIB variants and methods of use thereof) held by Keros Therapeutics, Inc. expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Keros Therapeutics, Inc.
- Grant date
- Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/00, A61K38/1709, A61K38/179, A61P